<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03800771</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A01109-46</org_study_id>
    <nct_id>NCT03800771</nct_id>
  </id_info>
  <brief_title>DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use</brief_title>
  <acronym>DOKTORBRAU</acronym>
  <official_title>DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to show the concordance between the dual-task test achieved usually&#xD;
      on an electronic treadmill and the dual-task test achieved with a cyclo-ergometer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Usually, dual task tests are only achieved on electronic treadmills. Patients who are coming&#xD;
      to perform these tests are mainly subjects with various levels of cognitive disorders and&#xD;
      with a high risk of fall because of potential motor and cognitive disorders.&#xD;
&#xD;
      The investigator will select patients referred for double task walking tests. After the&#xD;
      walking test, investigator will perform dual-task tests with a new bicycle device &quot;Cycléo&#xD;
      BRAU&quot; which allows the patients to achieve mental tasks while cycling. The aim of using a&#xD;
      bicycle is to limit the risk of falls compared to the treadmill or walking task. The &quot;Cycléo&#xD;
      BRAU&quot; device is equiped with a video projector which projects an environment of virtual&#xD;
      reality. It allows cycling without resistence and thus is not based on any incremental&#xD;
      worload. The mental tasks on bicycle will be of increasing difficulty and parameters such as&#xD;
      cycling speed will be recorded. Loss of speed regularity will be considered as an abnormal&#xD;
      response. The task for which cycling is stopped will be recorded and compared to the results&#xD;
      of the usual walking test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2019</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients are inhomogeneous in term of cognitive and physical function. The aim is to test faisability and security thus investigator will include a relatively large amount of patients.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Speed</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluate the concordance of the speed during the tests on treadmill and on cyclo-ergometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Speed variability</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluate the concordance the speed variability during the tests on treadmill and on cyclo-ergometer.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Elderly Patients</condition>
  <arm_group>
    <arm_group_label>Practice dual-task tests</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study consists to practice these dual-task tests with a new device which name is &quot;Cycléo BRAU&quot; that allows to the patients to achieve carefully an attentional task: cycle. Results will be compared tothe results obsvered during the routine GAITRITE analysis ( a validated tool for elderly patients and gait analysis).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cycléo BRAU</intervention_name>
    <description>Practice dual-task tests.</description>
    <arm_group_label>Practice dual-task tests</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GAITRITE®</intervention_name>
    <description>Routine practice dual-task tests.</description>
    <arm_group_label>Practice dual-task tests</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 60 years old&#xD;
&#xD;
          -  Patient with a near visual acuity upper or equal to 2/10&#xD;
&#xD;
          -  Patient with a score of MMSE upper than 10&#xD;
&#xD;
          -  Patient able to walk on a treadmill for 15 meters on straight line without help&#xD;
&#xD;
          -  Patient covered by the French health insurance&#xD;
&#xD;
          -  Patient (or support person or legal representative) able to understand the protocol&#xD;
&#xD;
          -  Patient (or support person or legal representative) agrees to be involve in the&#xD;
             protocol and sign the consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient has a wash-out period for another clinical trial&#xD;
&#xD;
          -  Patient with a medical contraindication to practice bicycle&#xD;
&#xD;
          -  Patient with locomotor disorders preexisting, whatever the reason&#xD;
&#xD;
          -  Patient needing extern help to walk like a walking frame, rollator or tricycle&#xD;
&#xD;
          -  Patient with a medical or surgical disease acute from less of 3 months&#xD;
&#xD;
          -  Patient with cerebrovascular accident history or any other cerebro-medullary diseases&#xD;
             with sensorimotor consequences&#xD;
&#xD;
          -  Patient with severe depression (Geriatric Depression Scale 15 items upper than 10)&#xD;
&#xD;
          -  Patient with a low proficiency of French (oral or written)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre ABRAHAM, MD; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital in Angers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denise JOLIVOT, MD</last_name>
    <phone>+33 241355808</phone>
    <email>denise.jolivot@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre ABRAHAM</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 20, 2018</study_first_submitted>
  <study_first_submitted_qc>January 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2019</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>geriatric</keyword>
  <keyword>dual-task</keyword>
  <keyword>ergometer</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

